2025 was a challenging year for the UK biotech sector, but it ended the year with signs of “renewed confidence,” says the BIA industry body.
Takeda is ‘not in favor’ of Trump’s MFN deals, CEO-designate says
Takeda’s incoming CEO took a firm stance against President Donald Trump’s “most favored nation” deals with drugmakers on Thursday, while Sanofi and Roche shared new


